Cardiovascular Disease in CKD in Children: Update on Risk Factors, Risk Assessment, and Management

American Journal of Kidney Diseases

Volumn 54, Issue 2, 2009, Pages 345-360

  Wilson, Amy C ^a   Mitsnefes, Mark M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

cardiovascular disease; children; Chronic kidney disease (CKD)

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PHOSPHORUS; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ATHEROSCLEROSIS; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; GLUCOSE METABOLISM; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; IMMOBILIZATION; INFLAMMATION; KIDNEY FAILURE; LARGE VESSEL DISEASE; LIFESTYLE MODIFICATION; MALNUTRITION; OBESITY; PHOSPHATE METABOLISM; PHYSICAL ACTIVITY; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; UREMIA;

CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 67650561881     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.027     Document Type: Review

References (131)

1. National Kidney Foundation Task Force on Cardiovascular Disease. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know?. What do we need to know? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32 suppl 3 (1998) S1-S121
2. US Renal Data System: USRDS 2003 Annual Report. The National Institute of Diabetes and Digestive and Kidney Diseases. http://www.usrds.org Accessed January 21, 2009
3. McDonald S.P., Craig J.C., and Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med 350 (2004) 2637-2639
4. Mitsnefes M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol 23 (2008) 27-39
5. Mitsnefes M.M., Ho P.-L., and McEnery P.T. Hypertension and the progression of chronic renal insufficiency in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14 (2003) 2618-2622
6. Loirat C., Ehrich J.H., Geerlings W., et al. Report on management of renal failure in children in Europe XXIII, 1992. Nephrol Dial Transplant 9 suppl 1 (1992) S26-S40
7. Lerner G.R., Warady B.A., Sullivan E.K., and Alexander S.R. Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 13 (1999) 404-417
8. Mitsnefes M.M., and Stablein D. Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45 (2005) 309-315
9. Smith J.M., Ho P.L., and McDonald R.A. Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 6 (2002) 493-499
10. Baluarte H.J., Gruskin A.B., Ingelfinger J.R., Stablein D., and Tejani A. Analysis of hypertension in children post renal transplantation-A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8 (1994) 570-573
11. Mitsnefes M.M., Khoury P.R., and McEnery P.T. Early post transplant hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143 (2003) 98-103
12. Wilson AC, Greenbaum LA, Barletta GM, et al: High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients [e-pub ahead of print]. Pediatr Transplant doi: 10.1111/j.1399-3046.2009.01141.x, accessed June 29, 2009
13. Feber J., Wong H., Geier P., Chaudry B., and Filler G. Complications of chronic kidney disease in children post-renal transplantation-A single center experience. Pediatr Transplant 12 (2008) 80-84
14. Flynn J.T., Mitsnefes M., Pierce C., et al. Blood pressure in children with chronic kidney disease: A report from the Chronic Kidney Disease in Children Study. Hypertension 52 (2008) 631-637
15. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis 41 (2003) S22-S38 (suppl 3)
16. Querfeld U., Salusky I.B., Nelson P., and Fine R.N. Hyperlipidemia in pediatric patients undergoing peritoneal dialysis. Pediatr Nephrol 2 (1988) 447-452
17. Querfeld U. Disturbances of lipid metabolism in children with chronic renal failure. Pediatr Nephrol 7 (1993) 749-757
18. Saland J.M., Ginsberg H., and Fisher E.A. Dyslipidemia in pediatric renal disease: Epidemiology, pathophysiology, and management. Curr Opin Pediatr 14 (2002) 197-204
19. Silverstein D.M., Palmer J., Polinsky M.S., Braas C., Conley S.B., and Baluarte H.J. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14 (2000) 105-110
20. Milliner D.S., Morgenstern B.Z., Murphy M., Gonyea J., and Sterioff S. Lipid levels following renal transplantation in pediatric recipients. Transplant Proc 26 (1994) 112-114
21. Chavers B.M., Hardstedt M., and Gillingham K.J. Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatr Nephrol 18 (2003) 565-569
22. Sgambat K., He J., McCarter R.J., and Moudgil A. Lipoprotein profile changes in children renal transplantation in the modern immunosuppression era. Pediatr Transplant 12 (2008) 796-803
23. Silverstein D.M., Mitchell M., LeBlanc P., and Boudreaux J.P. Assessment of risk factors for cardiovascular disease in pediatric renal transplant patients. Pediatr Transplant 11 (2007) 721-729
24. Saland J.M., Pierce C.B., Flynn J.T., et al. Dyslipidemia in children with CKD: A report of the Chronic Kidney Disease in Children (CKiD) Study (2008) Poster presented at: American Society of Nephrology Renal Week 2008, November 4-9, Philadelphia, PA
25. Hanevold C.D., Ho P.L., Talley L., and Mitsnefes M.M. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 115 (2005) 352-356
26. Mitsnefes M.M., Khoury P., and McEnery P.T. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 12 (2002) 535-539
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (2004) S5-S10 (suppl 1)
28. Prokai A., Fekete A., Kis E., et al. Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant 12 (2008) 643-649
29. Lai H.L., Kartal J., and Mitsnefes M. Hyperinsulinemia in pediatric patients with chronic kidney disease: The role of tumor necrosis factor-alpha. Pediatr Nephrol 22 (2007) 1751-1756
30. Lindblad Y.T., Axelsson J., Bárány P., et al. Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purif 26 (2008) 518-525
31. Painter P., Krasnoff J., and Mathias R. Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients. Pediatr Nephrol 22 (2007) 1030-1039
32. Weaver Jr. D.J., Kimball T.R., Knilans T., et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 19 (2008) 624-630
33. Vandevoorde R.G., Barletta G.M., Chand D.H., et al. Blood pressure control in pediatric hemodialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 22 (2007) 547-553
34. Ulinski T., Genty J., Viau C., Tillous-Borde I., and Deschênes G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21 (2006) 1171-1178
35. Mitstnefes M.M., Barletta G.M., Dresner I.G., et al. Severe cardiac hypertrophy and long-term dialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 21 (2006) 1167-1170
36. Fischbach M., Terzic J., Laugel V., et al. Daily on-line haemodiafiltration: A pilot trial in children. Nephrol Dial Transplant 19 (2004) 2360-2367
37. Fischbach M., Dheu C., Seuge L., Menouer S., and Terzic J. In-center daily on-line hemodiafiltration: A 4-year experience in children. Clin Nephrol 69 (2008) 279-284
38. Fadrowski J.J., Pierce C.B., Cole S.R., Moxey-Mims M., Warady B.A., and Furth S.L. Hemoglobin decline in children with chronic kidney disease: Baseline results from the Chronic Kidney Disease in Children Prospective Cohort Study. Clin J Am Soc Nephrol 3 (2008) 457-462
39. Staples A.O., Wong C.S., Smith J.M., et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 4 (2009) 48-56
40. Warady B.A., and Ho M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18 (2003) 1055-1062
41. El-Husseini A.A., Sobh M.A., and Ghonheim M.A. Complications of pediatric live-donor kidney transplantation: A single center's experience in Egypt. Pediatr Nephrol 23 (2008) 2067-2073
42. White C.T., Schisler T., Er L., Djurdjev O., and Matsuda-Abedini M. CKD following kidney transplantation in children and adolescents. Am J Kidney Dis 51 (2008) 996-1004
43. NAPRTCS. The NAPRTCS 2005 Annual Report. http://spitfire.emmes.com/study/ped/annlrept/annlrept2005.pdf Accessed February 10, 2009
44. Bek K., Akman S., Bilge I., et al. Chronic kidney disease in children in Turkey. Pediatr Nephrol 24 (2009) 797-806
45. 3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98 (1998) 1302-1306
46. Menon S., Valentini R.P., Hidalgo G., Peschansky L., and Mattoo T.K. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23 (2008) 1831-1836
47. Goldstein S.L., Currier H., Watters L., Hempe J.M., Sheth R.D., and Silverstein D. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143 (2003) 653-657
48. Cengiz N., Baskin E., Agras P.I., Sezgin N., and Saatci U. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis. Transplant Proc 37 (2005) 2915-2917
49. Sylvestre L.C., Fonseca K.P., Stinghen E.A., Pereira A.M., Meneses R.P., and Pecoits-Filho R. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol 22 (2007) 864-873
50. Goldstein S.L., Leung J.C., and Silverstein D.M. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: Effect of aspirin. Clin J Am Soc Nephrol 1 (2006) 979-986
51. Nurmohamed S.A., and Nube M.J. Reverse epidemiology: Paradoxical observations in haemodialysis patients. Neth J Med 63 (2005) 376-381
52. Silverstein D.M. Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease [e-pub ahead of print]. Pediatr Nephrol (2009) doi: 10.1007/s00467-008-1046-0, accessed June 29
53. Johnstone L.M., Jones C.L., Grigg L.E., Wilkinson J.L., Walker R.G., and Powell H.R. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50 (1996) 998-1006
54. Mitsnefes M.M., Kimball T.R., Witt S.A., Glascock B.J., Khoury P.R., and Daniels S.R. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107 (2003) 864-868
55. Poyrazoglu H.M., Düsünsel R., Narin F., et al. Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatr Nephrol 19 (2004) 193-198
56. Malikènas A., Cerniauskiene V., Jakutovic M., and Jankauskiene A. Left ventricular geometry in children with chronic renal failure. Medicina 41 (2005) S5-S11 (suppl 1)
57. Matteucci M.C., Wühl E., Picca S., et al. Left ventricular geometry in children with mild to moderate renal insufficiency. J Am Soc Nephrol 17 (2006) 218-226
58. Mitsnefes M.M., Kimball T.R., Kartal J., et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-Year follow-up study. J Pediatr 149 (2006) 671-675
59. Mitsnefes M., Flynn J., Cohn S., et al. Left ventricular hypertrophy and masked hypertension: A report from the Chronic Kidney Disease in Children (CKiD) cohort (2008) Poster presented at: American Society of Nephrology Renal Week 2008, November 4-9, Philadelphia, PA
60. Weaver D.J., Kimball T.R., Koury P.R., and Mitsnefes M.M. Cardiac output and associated left ventricular hypertrophy in pediatric chronic kidney disease. Pediatr Nephrol 24 (2009) 565-567
61. Drukker A., Urbach J., and Glaser J. Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension. Proc Eur Dial Transplant Assoc 18 (1981) 542-547
62. Morris K.P., Skinner J.R., Wren C., Hunter S., and Coulthard M.G. Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child 68 (1993) 637-643
63. Mitsnefes M.M., Daniels S.R., Schwartz S.M., Meyer R.A., Khoury P., and Strife C.F. Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol 14 (2000) 898-902
64. Mitsnefes M.M., Schwartz S.M., Daniels S.R., Kimball T.R., Khoury P., and Strife C.F. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5 (2001) 279-284
65. Lumpaopong A., Tuntrakool C., Thirakhupt P., and Chulamokha Y. Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents. J Med Assoc Thai 88 (2005) S202-S205 (suppl 3)
66. Uçar T., Tutar E., Yalçinkaya F., et al. Global left-ventricular function by tissue Doppler imaging in pediatric dialysis patients. Pediatr Nephrol 23 (2008) 779-785
67. Becker-Cohen R., Nir A., Ben-Shalom E., et al. Improved left ventricular mass index in children after renal transplantation. Pediatr Nephrol 23 (2008) 1545-1550
68. Guízar-Mendoza J.M., Amador-Licona N., Lozada E.E., et al. Left ventricular mass and heart sympathetic activity after renal transplantation in children and young adults. Pediatr Nephrol 21 (2006) 1413-1418
69. Matteucci M.C., Giordano U., Calzolari A., Turchetta A., Santilli A., and Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 56 (1999) 1566-1570
70. El-Husseini A.A., Sheashaa H.A., Hassan N.A., El-Demerdash F.M., Sobh M.A., and Ghoneim M.A. Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant 8 (2004) 249-254
71. Kitzmueller E., Véscei A., Pichler J., et al. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 19 (2004) 1385-1389
72. Bullington N., Kartal J., Khoury P., and Mitsnefes M. Left ventricular hypertrophy in pediatric kidney transplant recipients: Long-term follow-up study. Pediatr Transplant 10 (2006) 811-815
73. Muscheites J., Meyer A.A., Drueckler E., et al. Assessment of the cardiovascular system in pediatric chronic kidney disease: A pilot study. Pediatr Nephrol 23 (2008) 2233-2239
74. Gruppen M.P., Groothoff J.W., Prins M., et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int 63 (2003) 1058-1063
75. Goren A., Glaser J., and Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation: An echocardiographic assessment. Pediatr Nephrol 7 (1993) 725-728
76. Mitsnefes M.M., Kimball T.R., Border W.L., et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65 (2004) 1461-1466
77. Mitsnefes M.M., Kimball T.R., Border W.L., et al. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43 (2004) 721-726
78. Saygili A., Yildirim S.V., Cengiz N., Uslu Y., Tokel K., and Saatçi U. Assessment of left ventricular diastolic function by Doppler tissue imaging in children with end-stage renal disease. Acta Paediatr 94 (2005) 1055-1059
79. Chinali M., deSimone G., Matteucci M.C., et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 18 (2007) 593-598
80. Weaver Jr. D.J., Kimball T., Witt S.A., et al. Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr 153 (2008) 565-569
81. Groothoff J.W., Gruppen M.P., Offringa M., et al. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13 (2002) 2953-2961
82. Oh J., Wunsch R., Turzer M., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106 (2002) 100-110
83. Mitsnefes M.M., Kimball T.R., Witt S.A., Glascock B.J., Khoury P.R., and Daniels S.R. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 110 (2004) 97-101
84. Litwin M., Wühl E., Jourdan C., et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16 (2005) 1494-1500
85. Mitsnefes M.M., Kimball T.R., Kartal J., et al. Cardiac and vascular adaptation in pediatric patients with chronic renal disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol 16 (2005) 2799-2803
86. Briese S., Wiesner S., Will J.C., et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease: Impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21 (2006) 1906-1914
87. Poyrazoǧlu H.M., Düşünsel R., Yikilmaz A., et al. Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol 22 (2007) 109-116
88. Shroff R.C., Donald A.E., Hiorns M.P., et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18 (2007) 2996-3003
89. Bilginer Y., Ozaltin F., Basaran C.A., et al. Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery. Pediatr Transplant 11 (2007) 888-894
90. Van Summeren M.J.H., Hameleers J.M., Schurgers L.J., et al. Circulating calcification inhibitors and vascular properties in children after renal transplantation. Pediatr Nephrol 23 (2008) 985-993
91. Litwin M., Wühl E., Jourdan C., et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23 (2008) 2552-2557
92. Ziolkowska H., Brzewski M., and Roszkowska-Blaim M. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol 23 (2008) 805-811
93. Krmar R.T., Balzano R., Jogestrand T., Cedazo-Minguez A., Englund M.S., and Berg U.B. Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients. Pediatr Transplant 12 (2008) 412-419
94. Delucchi A., Dinamarca H., Gainza H., Whittle C., Torrealba I., and Iñiguez G. Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc 40 (2008) 3244-3246
95. Milliner D.S., Zinsmeister A.R., Lieberman E., and Landing B. Soft-tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38 (1990) 931-936
96. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
97. Ishitani M.B., Milliner D.S., Kim D.Y., et al. Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant 5 (2005) 1689-1693
98. Civilibal M., Caliskan S., Adaletli I., et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21 (2006) 1426-1433
99. Civilibal M., Caliskan S., Kurugoglu S., et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 24 (2009) 555-563
100. Johnson H.M., Douglas P.S., Srinivasan S.R., et al. Predictors of carotid intima-media thickness progression in young adults: The Bogalusa Heart Study. Stroke 38 (2007) 900-905
101. Litwin M., and Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 24 (2009) 709-719
102. Shroff R.C., McNair R., Figg N., et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118 (2008) 1748-1757
103. Kari J., Donald A.E., Vallance D.T., et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52 (1997) 468-472
104. Lilien M.R., Schröder C.H., Levtchenko E.N., and Koomans H.A. Growth hormone therapy influences endothelial function in children with renal failure. Pediatr Nephrol 19 (2004) 785-789
105. Lilien M.R., Stroes E.S., Op't Roodt J., de Jongh S., Schröder C.H., and Koomans H.A. Vascular function in children after renal transplantation. Am J Kidney Dis 41 (2003) 684-691
106. Lilien M.R., Koomans H.A., and Schröder C.H. Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol 20 (2005) 200-204
107. Wilson A.C., Urbina E., Witt S.A., Glascock B.J., Kimball T.R., and Mitsnefes M. Flow-mediated vasodilatation of brachial artery in children with chronic kidney disease. Pediatr Nephrol 23 (2008) 1297-1302
108. Kavey R.W., Allada V., Daniels S.R., et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science: The Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 114 (2006) 2710-2738
109. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 43 (2004) S223-S229 (suppl 1)
110. th report (2004) S555-S576
111. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis 41 (2003) S61-S70 (suppl 3)
112. Kasiske B., Cosio F.G., Beto J., et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 (2004) S13-S53 (suppl 7)
113. Daniels S.R., Greer F.R., and Committee on Nutrition. Lipid Screening and Cardiovascular Health in Childhood. Pediatrics 122 (2008) 198-208
114. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 35 (2000) S1-S140 (suppl 2)
115. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 (2003) S1-S202 (suppl 3)
116. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47 (2006) S1-S146 (suppl 3)
117. National Kidney Foundation. Section III. State of the science: Novel and controversial topics in cardiovascular diseases, in K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45 (2005) S76-S114 (suppl 3)
118. Nesrallah G., Suri R., Moist L., Kortas C., and Lindsay R.M. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42 (2003) 13-17
119. Fagugli R.M., Palumbo B., Ricciardi D., et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephron Clin Pract 95 (2003) 2322-2338
120. Chan C.T., Floras J.S., Miller J.A., Richardson R.M., and Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61 (2002) 2235-2239
121. Krmar R.T., and Berg U.B. Blood pressure control in hypertensive pediatric renal transplants: Role of repeated ABPM following transplantation. Am J Hypertens 21 (2008) 1093-1099
122. Wiesbauer F., Heinze G., Mitterbauer C., Harnoncourt F., Hörl W.H., and Oberbauer R. Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol 19 (2008) 2211-2218
123. Serón D., Oppenheimer F., Pallardó L.M., et al. Fluvastatin in the prevention of renal transplant vasculopathy: Results of a prospective, randomized, double-blind, placebo-controlled trial. Transplantation 15 (2008) 82-87
124. Hakim R.M., and Lowrie E. Obesity and mortality in ESRD: Is it good to be fat?. Kidney Int 55 (1999) 1580-1581
125. Cheung A.K., Sarnak M.J., Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58 (2000) 353-362
126. Kopple J.D. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43 (1997) 246-250
127. Nishizawa Y., Shoji T., and Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J Ren Nutr 16 (2006) 241-244
128. Hanevold C.D., Ho P.L., Talley L., and Mitsnefes M.M. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 115 (2005) 352-356
129. Mitsnsefes M.M., Khoury P., and McEnery P.T. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 17 (2002) 535-539
130. Hanafy S., Pinsk M., and Jamali F. Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease. Pediatr Nephrol 24 (2009) 815-821
131. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 (2005) S4-S36 (suppl 1)